Clinical Trials Directory

Trials / Unknown

UnknownNCT03221504

7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children

7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
221 (estimated)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
All
Age
3 Months – 7 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to assess the effectiveness of a 7-day compared with a 10-day course of antibiotic treatment for febrile urinary tract infections (UTIs) in children. It is formulated a hypothesis that a 7-day course of antibiotic therapy is equally effective as a 10-day course of therapy and would entail a lower risk of adverse events and better compliance.

Detailed description

In previously published European and global guidelines, there has been no consensus among experts regarding the duration of therapy for a febrile UTI. Depending on the recommendation, the duration of treatment should be between 7-14 days. 221 patients aged 3 months to 7 years with febrile UTIs (defined as a combination of fever and leukocyturia in urine sediment) will be randomly assigned to receive a 7-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded placebo) or a 10-day treatment arm (7 days of cefuroxime/cefuroxime axetil followed by 3 days of blinded cefuroxime axetil). The primary outcome measure will be frequencies of recurrence and reinfection of UTI during the 6 months after the intervention. The secondary outcome measures will be antibiotic-associated diarrhea and compliance.

Conditions

Interventions

TypeNameDescription
OTHERLonger therapy durationPatients will receive cefuroxime axetil orally. Treatment will involve the supply of cefuroxime axetil 30 mg/kg/d in two divided doses (in blinded bottles).
OTHERShorter therapy durationPatients will receive placebo orally (in blinded bottles). The volume of the placebo will be like cefuroxime syrup.

Timeline

Start date
2018-01-01
Primary completion
2019-07-31
Completion
2020-01-31
First posted
2017-07-18
Last updated
2018-03-20

Locations

2 sites across 1 country: Poland

Source: ClinicalTrials.gov record NCT03221504. Inclusion in this directory is not an endorsement.